Christopher Kenneth Savile

Christopher Kenneth Savile is a declared insider of Willow Biosciences Inc., with filings sourced from SEDI. The record holds 12 filings, for trades running from 7 April 2020 to 18 July 2024.

Both buying and selling appear: 4 purchases worth €20k, against 1 sale worth €724. Purchases outweigh sales by €19k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 3 option exercises.

In size, the median ticket on the buying side is €4,264. No cluster: in 3 purchases, no other insider of the company bought within 30 days.

Most recently, on 18 July 2024, the filings show a transaction worth €20k in Willow Biosciences Inc. The latest purchase dates back some time: it was published 1,060 days ago, on 30 November 2023. Filings reach the SEDI feed a median of 1 day after the trade. Until a filing is published, the market cannot know about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.